Assembly Biosciences ASMB Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $8.21M-12.8% | $42.47M+477% | $10.79M+57.6% | $9.63M+12.8% | $9.42M+62.8% | ||
| $14.9M+0.3% | $17.25M+20.8% | $16.59M+22.7% | $16.13M-0.8% | $14.85M+25.0% | ||
| $4.68M+3.9% | $5.42M+17.6% | $5.09M+18.6% | $4.59M+2.6% | $4.51M-2.7% | ||
| $19.58M+1.2% | $22.67M+20.0% | $21.67M+21.7% | $20.72M-0.1% | $19.36M+17.2% | ||
| $19.58M+1.2% | $22.67M+20.0% | $21.67M+21.7% | $20.72M-0.1% | $19.36M+17.2% | ||
| -$11.37M-14.4% | —— | -$10.88M+0.7% | -$11.09M+9.1% | -$9.94M+7.3% | ||
| -138.4%-32.9pp | —— | -100.9%+59.2pp | -115.2%+27.8pp | -105.5%+79.9pp | ||
| $2.29M+104% | $2.29M+104% | $1.69M+25.6% | $895K-38.6% | $1.12M-32.0% | ||
| $2.29M+104% | $2.29M+104% | $1.69M+25.6% | $895K-38.6% | $1.12M-32.0% | ||
| -$9.08M-3.0% | —— | -$9.2M+4.3% | -$10.2M+8.6% | -$8.82M+2.9% | ||
| -110.5%-16.9pp | —— | -85.2%+55.2pp | -105.9%+24.8pp | -93.6%+63.3pp | ||
| -$0.54+53.8% | —— | -$0.72+52.3% | -$1.33+32.8% | -$1.17+29.5% | ||
| -$0.54+53.8% | —— | -$0.72+52.3% | -$1.33+32.8% | -$1.17+29.5% | ||
| 16.9M+125% | 11.2M+86.7% | 12.7M+99.7% | 7.7M+35.7% | 7.5M+36.9% | ||
| 16.9M+125% | 11.2M+86.7% | 12.7M+99.7% | 7.7M+35.7% | 7.5M+36.9% | ||
| -$9.41M-6.2% | —— | -$9.01M+4.9% | -$10.22M+8.8% | -$8.86M+4.1% | ||
| $2.29M+104% | $2.29M+104% | $1.69M+25.6% | $895K-38.6% | $1.12M-32.0% | ||
| -$327K-679% | $49K+189% | $189K+38.0% | -$26K+51.9% | -$42K+73.4% | ||
| —— | $18.08M+154% | $18.08M+154% | $18.08M+154% | $18.08M+154% | ||
| -$11.37M-14.4% | —— | -$10.88M+0.7% | -$11.09M+9.1% | -$9.94M+7.3% | ||
| -$11.34M-14.5% | —— | -$10.85M+0.7% | -$11.06M+9.1% | -$9.91M+7.4% | ||
| -$11.34M-14.5% | —— | -$10.85M+0.7% | -$11.06M+9.1% | -$9.91M+7.4% | ||
| -138.1%-32.9pp | —— | -100.6%+59.0pp | -114.9%+27.7pp | -105.2%+79.7pp | ||
| -$11.37M-14.4% | —— | -$10.88M+0.7% | -$11.09M+9.1% | -$9.94M+7.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Assembly Biosciences's revenue?
- Assembly Biosciences (ASMB) generated $71.1M in revenue over the trailing twelve months, up 121.1% year over year.
- Is Assembly Biosciences profitable?
- Assembly Biosciences is not currently profitable: it reported a net loss of $37.3M over the trailing twelve months, a -103.6% net margin.
- What is Assembly Biosciences's earnings per share?
- Assembly Biosciences's diluted EPS over the trailing twelve months is $-3.76.
- Where does Assembly Biosciences's income statement data come from?
- Every line is extracted from Assembly Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
